1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RP11-613M10.8 CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA RNF219 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA MRPL50 CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA RNF126 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA TRA2B CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA CRIM1 CTRPv2 pan-cancer AAC -0.17 4e-06
mRNA PRIMPOL CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA SRP9 CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA NAA15 CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA SRPK1 CTRPv2 pan-cancer AAC 0.15 5e-06
Download CSV